186 related articles for article (PubMed ID: 33987398)
1. PSMD12 promotes glioma progression by upregulating the expression of Nrf2.
Wang Z; Li Z; Xu H; Liao Y; Sun C; Chen Y; Sheng M; Lan Q; Wang Z
Ann Transl Med; 2021 Apr; 9(8):700. PubMed ID: 33987398
[TBL] [Abstract][Full Text] [Related]
2. PSMD12 promotes non-small cell lung cancer progression through activating the Nrf2/TrxR1 pathway.
Lv J; Ma S; Wang X; Dang J; Ma F
Genes Genomics; 2024 Mar; 46(3):263-277. PubMed ID: 38243044
[TBL] [Abstract][Full Text] [Related]
3. PSMD12 promotes the activation of the MEK-ERK pathway by upregulating KIF15 to promote the malignant progression of liver cancer.
Zhang H; Li C; Liao S; Tu Y; Sun S; Yao F; Li Z; Wang Z
Cancer Biol Ther; 2022 Dec; 23(1):1-11. PubMed ID: 36137220
[TBL] [Abstract][Full Text] [Related]
4. PSMD12 promotes breast cancer growth via inhibiting the expression of pro-apoptotic genes.
Du X; Shen X; Dai L; Bi F; Zhang H; Lu C
Biochem Biophys Res Commun; 2020 May; 526(2):368-374. PubMed ID: 32222279
[TBL] [Abstract][Full Text] [Related]
5. PSMD12 interacts with CDKN3 and facilitates pancreatic cancer progression.
Ma J; Zhou W; Yuan Y; Wang B; Meng X
Cancer Gene Ther; 2023 Aug; 30(8):1072-1083. PubMed ID: 37037907
[TBL] [Abstract][Full Text] [Related]
6. Microrchidia family CW‑type zinc finger 2 promotes the proliferation, invasion, migration and epithelial‑mesenchymal transition of glioma by regulating PTEN/PI3K/AKT signaling via binding to N‑myc downstream regulated gene 1 promoter.
Zhang J; Yang Y; Dong Y; Liu C
Int J Mol Med; 2022 Feb; 49(2):. PubMed ID: 34913078
[TBL] [Abstract][Full Text] [Related]
7. TRAF3IP3 promotes glioma progression through the ERK signaling pathway.
Lin Q; Chen Z; Shen ZL; Xue F; Qin JJ; Kang XP; Chen ZR; Xia ZY; Gao L; Chen XZ
Front Oncol; 2022; 12():776834. PubMed ID: 36185204
[TBL] [Abstract][Full Text] [Related]
8. CD147 confers temozolomide resistance of glioma cells via the regulation of β-TrCP/Nrf2 pathway.
Bu X; Qu X; Guo K; Meng X; Yang X; Huang Q; Dou W; Feng L; Wei X; Gao J; Sun W; Chao M; Han L; Hu Y; Shen L; Zhang J; Wang L
Int J Biol Sci; 2021; 17(12):3013-3023. PubMed ID: 34421346
[No Abstract] [Full Text] [Related]
9. De Novo Disruption of the Proteasome Regulatory Subunit PSMD12 Causes a Syndromic Neurodevelopmental Disorder.
Küry S; Besnard T; Ebstein F; Khan TN; Gambin T; Douglas J; Bacino CA; Craigen WJ; Sanders SJ; Lehmann A; Latypova X; Khan K; Pacault M; Sacharow S; Glaser K; Bieth E; Perrin-Sabourin L; Jacquemont ML; Cho MT; Roeder E; Denommé-Pichon AS; Monaghan KG; Yuan B; Xia F; Simon S; Bonneau D; Parent P; Gilbert-Dussardier B; Odent S; Toutain A; Pasquier L; Barbouth D; Shaw CA; Patel A; Smith JL; Bi W; Schmitt S; Deb W; Nizon M; Mercier S; Vincent M; Rooryck C; Malan V; Briceño I; Gómez A; Nugent KM; Gibson JB; Cogné B; Lupski JR; Stessman HAF; Eichler EE; Retterer K; Yang Y; Redon R; Katsanis N; Rosenfeld JA; Kloetzel PM; Golzio C; Bézieau S; Stankiewicz P; Isidor B
Am J Hum Genet; 2017 Feb; 100(2):352-363. PubMed ID: 28132691
[TBL] [Abstract][Full Text] [Related]
10. Kiaa0101 serves as a prognostic marker and promotes invasion by regulating p38/snail1 pathway in glioma.
Liu J; Gao L; Liao J; Yang J; Yuan F; Chen Q
Ann Transl Med; 2021 Feb; 9(3):260. PubMed ID: 33708887
[TBL] [Abstract][Full Text] [Related]
11. Elevated O-GlcNAcylation Promotes Malignant Phenotypes of Hypopharyngeal Squamous Cell Carcinoma by Stabilizing Nrf2 through Regulation of the PI3K/Akt Pathway.
Dai W; Jin X; Jiang B; Chen W; Ji Z; Xu X; Tang M; Dai K; Han L
Anticancer Agents Med Chem; 2020; 20(16):1933-1942. PubMed ID: 32538734
[TBL] [Abstract][Full Text] [Related]
12. CBX3 promotes glioma U87 cell proliferation and predicts an unfavorable prognosis.
Zhao SP; Wang F; Yang M; Wang XY; Jin CL; Ji QK; Li S; Zhao XL
J Neurooncol; 2019 Oct; 145(1):35-48. PubMed ID: 31502042
[TBL] [Abstract][Full Text] [Related]
13. Long non‑coding RNA NEAT1 regulates glioma cell proliferation and apoptosis by competitively binding to microRNA‑324‑5p and upregulating KCTD20 expression.
Zhang J; Li Y; Liu Y; Xu G; Hei Y; Lu X; Liu W
Oncol Rep; 2021 Jul; 46(1):. PubMed ID: 33982764
[TBL] [Abstract][Full Text] [Related]
14. Knockdown of NF-E2-related factor 2 inhibits the proliferation and growth of U251MG human glioma cells in a mouse xenograft model.
Ji XJ; Chen SH; Zhu L; Pan H; Zhou Y; Li W; You WC; Gao CC; Zhu JH; Jiang K; Wang HD
Oncol Rep; 2013 Jul; 30(1):157-64. PubMed ID: 23673813
[TBL] [Abstract][Full Text] [Related]
15. SNAP25 Inhibits Glioma Progression by Regulating Synapse Plasticity
Huang Q; Lian C; Dong Y; Zeng H; Liu B; Xu N; He Z; Guo H
Front Oncol; 2021; 11():698835. PubMed ID: 34490096
[TBL] [Abstract][Full Text] [Related]
16. Long noncoding RNA LINC01426 promotes glioma progression through PI3K/AKT signaling pathway and serves as a prognostic biomarker.
Wang SJ; Wang H; Zhao CD; Li R
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(19):6358-6368. PubMed ID: 30338804
[TBL] [Abstract][Full Text] [Related]
17. Cullin-7 (CUL7) is overexpressed in glioma cells and promotes tumorigenesis via NF-κB activation.
Xu J; Zhang Z; Qian M; Wang S; Qiu W; Chen Z; Sun Z; Xiong Y; Wang C; Sun X; Zhao R; Xue H; Li G
J Exp Clin Cancer Res; 2020 Apr; 39(1):59. PubMed ID: 32252802
[TBL] [Abstract][Full Text] [Related]
18. CUX1 Facilitates the Development of Oncogenic Properties
Feng F; Zhao Z; Zhou Y; Cheng Y; Wu X; Heng X
Front Mol Biosci; 2021; 8():705008. PubMed ID: 34422906
[No Abstract] [Full Text] [Related]
19. Overexpression of PLOD3 promotes tumor progression and poor prognosis in gliomas.
Tsai CK; Huang LC; Tsai WC; Huang SM; Lee JT; Hueng DY
Oncotarget; 2018 Mar; 9(21):15705-15720. PubMed ID: 29644003
[TBL] [Abstract][Full Text] [Related]
20. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
